| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 9 |
| 1 | THIOTEPA | 9 |
| 2 | FLUDARABINE PHOSPHATE | 8 |
| 3 | METHYLPREDNISOLONE | 8 |
| 4 | ANAKINRA | 7 |
| 5 | PREDNISOLONE | 7 |
| 6 | PREDNISOLONE ORAL | 7 |
| 7 | PREDNISOLONE ORAL SOLUTION | 7 |
| 8 | METHOTREXATE | 6 |
| 9 | METHOTREXATE SODIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUMASIRAN | 1 | 0.0026 |
| 1 | ETEPLIRSEN | 4 | 0.0017 |
| 2 | DEFLAZACORT | 3 | 0.0012 |
| 3 | DINUTUXIMAB | 1 | 0.0012 |
| 4 | THIOTEPA | 9 | 0.0009 |
| 5 | NIRSEVIMAB | 1 | 0.0006 |
| 6 | DACTINOMYCIN | 1 | 0.0005 |
| 7 | ANAKINRA | 7 | 0.0004 |
| 8 | FIDAXOMICIN | 1 | 0.0004 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 2 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 3 | Actinomycin [EPC] | 1 | 0.0005 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 7 | 0.0004 |
| 5 | Antisense Oligonucleotide [EPC] | 4 | 0.0003 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 7 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |